These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 915905)
1. Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity. Smith CW; Botos CR; Skala G; Walter R J Med Chem; 1977 Nov; 20(11):1457-60. PubMed ID: 915905 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin. Smith CW; Skala G; Walter R J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140 [TBL] [Abstract][Full Text] [Related]
3. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones. Walter R; Smith CW; Roy J; Formento A J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7. Moore S; Felix AM; Meienhofer J; Smith CW; Walter R J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234 [TBL] [Abstract][Full Text] [Related]
5. Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin. Walter R; Stahl GL; Caplaneris T; Cordopatis P; Theodoropoulos D J Med Chem; 1979 Jul; 22(7):890-3. PubMed ID: 448689 [TBL] [Abstract][Full Text] [Related]
6. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin. Roy J; Roy U; Gazis DC; Schwartz IL Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004 [TBL] [Abstract][Full Text] [Related]
7. Dose-response behavior on the isolated rat uterus of oxytocin analogs with modifications at binding sites. Smith CW; Chan S; Walter R J Pharmacol Exp Ther; 1977 Oct; 203(1):120-4. PubMed ID: 909047 [TBL] [Abstract][Full Text] [Related]
8. Importance of the third amino acid residue of oxytocin for its action on isolated rat uterus: study of relationship between hormone conformation and activity. Walter R; Smith CW; Roy J Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3054-8. PubMed ID: 184456 [TBL] [Abstract][Full Text] [Related]
9. Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide. Ting YF; Smith CW; Stahl GL; Walter R; Cordopatis P; Theodoropoulos D J Med Chem; 1980 Jun; 23(6):693-5. PubMed ID: 7392037 [TBL] [Abstract][Full Text] [Related]
10. Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones. Stahl GL; Smith CW; Walter R; Tsegenidis T; Stavropoulos G; Cordopatis P; Theodoropoulos D J Med Chem; 1980 Feb; 23(2):213-7. PubMed ID: 7359537 [TBL] [Abstract][Full Text] [Related]
11. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin. Nestor JJ; Ferger MF; Chan WY J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680 [TBL] [Abstract][Full Text] [Related]
12. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin. Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141 [TBL] [Abstract][Full Text] [Related]
13. Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation. Lebl M; Hill P; Kazmierski W; Kárászová L; Slaninová J; Fric I; Hruby VJ Int J Pept Protein Res; 1990 Oct; 36(4):321-30. PubMed ID: 2079387 [TBL] [Abstract][Full Text] [Related]
14. Synthetic metabolites of neurohypophyseal hormones. (Des-9-glycinamide)oxytocin and (des-9-glycinamide, des-8-leucine)oxytocin. Walter R; Havran RT; Schwartz IL J Med Chem; 1976 Feb; 19(2):328-30. PubMed ID: 1249815 [TBL] [Abstract][Full Text] [Related]
15. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1. Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin. Ferger MF; Chan WY J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7. Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912 [TBL] [Abstract][Full Text] [Related]
18. Conformationally biased analogs of oxytocin. Lebl M; Toth G; Slaninová J; Hruby VJ Int J Pept Protein Res; 1992 Aug; 40(2):148-51. PubMed ID: 1446971 [TBL] [Abstract][Full Text] [Related]
19. [4-(0-methyl)-L-threonine] -oxytocin. Synthesis and uterotonic activity. Bańkowski K Pol J Pharmacol Pharm; 1988; 40(3):331-5. PubMed ID: 2853867 [TBL] [Abstract][Full Text] [Related]
20. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8. Flouret G; Chaloin O; Slaninová J J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]